HSBC Holdings’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-127,342
| Closed | -$109K | – | 2682 |
|
|
2022
Q4 | $109K | Hold |
127,342
| – | – | ﹤0.01% | 2406 |
|
|
2022
Q3 | $205K | Sell |
127,342
-33,391
| -21% | -$53.8K | ﹤0.01% | 2186 |
|
|
2022
Q2 | $326K | Buy |
160,733
+129,234
| +410% | +$262K | ﹤0.01% | 2187 |
|
|
2022
Q1 | $75K | Buy |
31,499
+860
| +3% | +$2.05K | ﹤0.01% | 2778 |
|
|
2021
Q4 | $145K | Buy |
30,639
+16,352
| +114% | +$77.4K | ﹤0.01% | 2608 |
|
|
2021
Q3 | $108K | Sell |
14,287
-1,208
| -8% | -$9.13K | ﹤0.01% | 2407 |
|
|
2021
Q2 | $150K | Buy |
+15,495
| New | +$150K | ﹤0.01% | 2368 |
|
|
2021
Q1 | – | Sell |
-28,673
| Closed | -$199K | – | 2694 |
|
|
2020
Q4 | $199K | Buy |
+28,673
| New | +$199K | ﹤0.01% | 2381 |
|
|
2019
Q4 | – | Sell |
-10,034
| Closed | -$21K | – | 2574 |
|
|
2019
Q3 | $21K | Buy |
+10,034
| New | +$21K | ﹤0.01% | 2429 |
|